Skip to content
Tech News
← Back to articles

Revealed: inside the US military's plan to tap huge sums from the NIH

read original more articles
Why This Matters

The US NIH's plan to transfer hundreds of millions of dollars in research projects to the Department of Defense marks a significant shift in the allocation of federal research funding, potentially impacting public health initiatives and biodefense strategies. This move highlights the increasing overlap between civilian health research and military priorities, raising questions about transparency and the future focus of biomedical research.

Key Takeaways

Scientists work in a laboratory at the National Institutes of Allergy and Infectious Diseases, which could lose research projects to the US Department of Defense.Credit: NIAID

The US National Institutes of Health (NIH) is seeking to redirect research projects worth hundreds of millions of dollars from its infectious-diseases institute to military biodefence programmes at the US Department of Defense (DOD), according to two NIH employees.

They confirmed to Nature that the NIH and the DOD, also called the Department of War, have signed an agreement for the arrangement. The NIH is now identifying projects it would transfer to the DOD and aims to complete the agreement by the end of September, when the fiscal year ends and some funds expire, according to a third NIH employee who is a senior official at the agency. (The employees spoke on the condition of anonymity because they are not authorized to speak to the press.)

An NIH spokesperson says, “This partnership will only take place on a project-by-project basis, and all research will be within the scope of NIH’s mission. There is no blanket transfer of funds”.

Exclusive: NIH ousts infectious-disease leaders as COVID scientists face US charges

The senior NIH official said the new arrangement would untangle civilian public-health initiatives from defence priorities. “We’re trying to get research that’s more Department of War-related back to Department of War,” the official said. “When the public hears that NIAID funds biodefence, they think we’re developing bioweapons, and we’re trying to get out of that business.”

Federal law does allow agreements between US agencies to share funding in some circumstances, says Samuel Bagenstos, who until December 2025 was the top lawyer for the NIH’s parent agency, the Department of Health and Human Services. But “what’s not appropriate or legal is saying, ‘Look, DOD needs money, NIH has money, we’re going to take money and send it to the DOD,’” he says. If the administration is using NIH resources to cover military budget shortfalls, “that would be illegal, because that would be using funding not to serve the purposes of NIH, but to serve the purposes of DOD.”

The agreement would establish a pathway to move funding out of the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), the country’s premier infectious-disease research institute, to support defence initiatives and will last 10 years, according to the three sources. The full agreement has not yet been finalized, the sources say.

Biosecurity researchers warn that shifting biomedical research to the military threatens the transparency and clinical translation that define NIH-funded work. “The Department of Defense is just not set up to deliver the scientific innovations we have come to expect and rely on from NIH,” says Gigi Gronvall, a biosecurity specialist at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.

Bureaucratic churn

... continue reading